Understanding how proteins are made and regulated in the body
Mechanisms of action of human translation initiation factors and their regulation
This study is looking at how certain factors help start the process of making proteins in our bodies, especially when we're under stress, and it aims to understand how a specific factor called eIF2B might be linked to diseases like Alzheimer's and cancer, which could help develop new treatments for these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10693180 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind the initiation of protein synthesis, focusing on the role of specific factors that regulate this process. It examines how these factors interact within a complex system to control protein production, especially under stress conditions. By using advanced techniques like NMR and biochemical assays, the study aims to uncover the functions of eIF2B, a key player in this regulation, and how its dysregulation may contribute to diseases such as Alzheimer's and cancer. The findings could lead to new therapeutic strategies for these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or other neurodegenerative disorders.
Not a fit: Patients with non-neurodegenerative conditions or those not affected by protein synthesis dysregulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments that protect neurons and improve outcomes for patients with neurodegenerative diseases.
How similar studies have performed: Previous research has shown promise in targeting similar pathways for neuroprotection, indicating potential for success in this approach.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Marintchev, Assen G — Boston University Medical Campus
- Study coordinator: Marintchev, Assen G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.